A Study of Tadalafil in Men With Benign Prostatic Hyperplasia

Clinical trial NCT00970632 · COMPLETED

Trial details

NCT number: NCT00970632
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Benign Prostatic Hyperplasia (BPH)

Start date: 2009-10-01
Primary completion: 2011-01-01
Enrollment: 511

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.